Recurrent granulocytic sarcoma. An unusual variation of acute myelogenous leukemia associated with 8; 21 chromosomal translocation and blast expression of the …
JC Byrd, RB Weiss - Cancer, 1994 - Wiley Online Library
This study reports on a patient with acute myelogenous leukemia (AML) in remission who
had a series of 11 granulocytic sarcomas (chloromas or myeloblastomas) appearing …
had a series of 11 granulocytic sarcomas (chloromas or myeloblastomas) appearing …
Endothelial cells: major players in acute myeloid leukaemia
S Fodil, M Arnaud, C Vaganay, A Puissant, E Lengline… - Blood Reviews, 2022 - Elsevier
The role of the vascular microenvironment is increasingly studied in acute myeloid
leukaemia (AML). Complex interactions between endothelial cells (ECs) and pre-leukaemic …
leukaemia (AML). Complex interactions between endothelial cells (ECs) and pre-leukaemic …
All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol: Presented in …
MS Tallman, JW Andersen, CA Schiffer… - Blood, The Journal …, 2002 - ashpublications.org
We previously reported a benefit for all-trans retinoic acid (ATRA) in both induction and
maintenance therapy in patients with acute promyelocytic leukemia (APL). To determine the …
maintenance therapy in patients with acute promyelocytic leukemia (APL). To determine the …
Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcome
H Chang, J Brandwein, K Chun, B Patterson, B Brien - Leukemia Research, 2004 - Elsevier
We evaluated the frequency and prognostic significance of extramedullary infiltrates (EMI) at
presentation of acute myeloid leukemia (AML) in adult patients. Of 331 cases with de novo …
presentation of acute myeloid leukemia (AML) in adult patients. Of 331 cases with de novo …
Extramedullary leukemia in children with newly diagnosed acute myeloid leukemia: a report from the Children's Cancer Group
KE Dusenbery, WB Howells, DC Arthur… - Journal of pediatric …, 2003 - journals.lww.com
Objectives To describe features of patients with acute myeloid leukemia presenting with
extramedullary leukemic tumors (EML). Methods Among 1,832 patients entered on …
extramedullary leukemic tumors (EML). Methods Among 1,832 patients entered on …
CD7+ and CD56+ Myeloid/Natural Killer Cell Precursor Acute Leukemia: A Distinct Hematolymphoid Disease Entity
R Suzuki, K Yamamoto, M Seto… - Blood, The Journal …, 1997 - ashpublications.org
The disease spectrum of natural killer (NK) cell leukemias and lymphomas has recently
been expanding with the continuing evolution in diagnostic concepts. We describe here …
been expanding with the continuing evolution in diagnostic concepts. We describe here …
CD56 expression in acute promyelocytic leukemia: a possible indicator of poor treatment outcome?
CK Murray, E Estey, E Paietta, RS Howard… - Journal of Clinical …, 1999 - ascopubs.org
PURPOSE: Blast expression of CD56 is frequent in patients with t (8; 21)(q22; q22) acute
myeloid leukemia and is associated with an inferior outcome. The expression of CD56 has …
myeloid leukemia and is associated with an inferior outcome. The expression of CD56 has …
Grading of symptoms in hyperleukocytic leukaemia: a clinical model for the role of different blast types and promyelocytes in the development of leukostasis syndrome
JR Novotny, H Müller‐Beißenhirtz… - European journal of …, 2005 - Wiley Online Library
Objective: Patients with hyperleukocytic leukaemia were graded according to the severity of
symptoms possibly caused by leukostasis to evaluate the effectiveness of therapy and to test …
symptoms possibly caused by leukostasis to evaluate the effectiveness of therapy and to test …
T cell and NK cell lymphoproliferative disorders
JP Greer, MC Kinney… - ASH Education Program …, 2001 - ashpublications.org
This review covers the diagnosis and management of natural killer and peripheral T-cell
lymphomas (PTCL). Problems with PTCL include their rarity, representing usually 10-15% of …
lymphomas (PTCL). Problems with PTCL include their rarity, representing usually 10-15% of …
High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML)
M Graf, S Reif, K Hecht, R Pelka-Fleischer, T Kroell… - Annals of …, 2005 - Springer
Costimulatory molecules such as lymphocyte function-associated antigen (LFA)-1 (CD11a),
LFA-3 (CD58), intercellular adhesion molecule (ICAM)-1 (CD54), neuronal cell adhesion …
LFA-3 (CD58), intercellular adhesion molecule (ICAM)-1 (CD54), neuronal cell adhesion …